Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
暂无分享,去创建一个
D. Hommes | S. Hanauer | G. D'Haens | W. Sandborn | W. Reinisch | R. Panaccione | R. Thakkar | R. Fedorak | Bidan Huang | A. Lazar | W. Kampman | M. Tighe | S. Schreiber